Smith & Nephew

Smith & Nephew

Makes Truclear, a product that removes polyps, fibroids and other abnormal tissue from the uterus.

Launch date
Employees
Market cap
$13.6b
Enterprise valuation
$16.7b (Public information from Sep 2024)
Company register number 00324357
Watford England (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues4.6b5.2b5.2b5.5b5.8b6.1b6.4b
% growth(11 %)14 %-6 %5 %5 %5 %
EBITDA904m1.2b943m1.2b1.4b1.6b1.7b
% EBITDA margin20 %22 %18 %21 %25 %26 %27 %
Profit448m524m223m263m462m640m764m
% profit margin10 %10 %4 %5 %8 %10 %12 %
EV / revenue4.4x3.4x2.7x2.7x2.8x2.6x2.4x
EV / EBITDA22.1x14.9x15.0x12.4x11.1x9.9x9.0x
R&D budget307m356m345m299m---
R&D % of revenue7 %7 %7 %5 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$350m

Valuation: $350m

0.3x EV/LTM EBITDA

Acquisition
*

$204k

Post IPO Equity
Total Funding-

Recent News about Smith & Nephew

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Smith & Nephew

Edit
Brainlab
ACQUISITION by Smith & Nephew Jun 2019
CartiHeal
ACQUISITION by Smith & Nephew Nov 2023
OrthoSpace
ACQUISITION by Stryker Mar 2019
Arthrocare
ACQUISITION by Smith & Nephew Feb 2014
Rotation Medical
ACQUISITION by Smith & Nephew Oct 2017
Kalypto Medical
ACQUISITION by Smith & Nephew May 2012
LIFEMODELER
ACQUISITION by Smith & Nephew Apr 2012
Blue Belt Technologies
ACQUISITION by Smith & Nephew Nov 2015
View 9 more